Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
Douglas C. Palmer(AstraZeneca (Japan)), Steven A. Rosenberg(National Cancer Institute)
Cited by 11
Related Papers
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
|Journal of Clinical Oncology|2008|1.3k
IL-2: The First Effective Immunotherapy for Human Cancer
|The Journal of Immunology|2014|1.3k
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
|Journal of Clinical Investigation|2014|1.1k
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
|The Journal of Experimental Medicine|1996|547
mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
|Journal of Clinical Investigation|2020|409